Back to search

University of Sheffield

Membrane microdomains as therapeutic targets to control respiratory syncytial virus

Abstract

dc:description.abstract

Respiratory syncytial virus (RSV) infects most individuals by the age of two years old with reinfections occurring throughout life. RSV causes a wide spectrum of disease, contributing to high rates of morbidity and mortality in very young, elderly, and immunocompromised individuals. Severe RSV infections have been linked to an excessive and deleterious host immune response that can lead to pulmonary complications such as bronchiolitis. There are currently no established vaccines against RSV, and new treatments for infection are still in development and not established in routine practice. Membrane microdomains (MM) are specialised regions of host cell membranes that play crucial roles in inflammatory cell signalling and are utilised as platforms for the adsorption and infection of enveloped viruses such as RSV. Previous studies have reported that a naturally occurring phosphatidylserine lipid species, SAPS, can perturb MM and the associated proinflammatory response induced by rhinovirus. I hypothesised that SAPS may be used to disrupt MM, modulating the immune response and the life cycle of RSV in airway epithelial cells (AEC)s. I further hypothesised that SAPS inhibitory effects may also prevent subsequent bacterial co-infection in RSV-infected cells. AECs were infected with RSV and incubated with SAPS either during infection or at a range of times post-infection. RSV infected AECs co-incubated with SAPS exhibited significantly decreased release of CXCL8 and CCL5 up to 48 hours when compared to untreated cells alone or RSV infected cells co-incubated with the comparative liposome PAPC. Furthermore, AECs infected with RSV in the presence of SAPS had significantly reduced numbers of infected cells and subsequent viral replication in comparison to controls. Preliminary data has also demonstrated that SAPS can significantly reduce the adhesion of Streptococcus pneumoniae to AECs directly and inhibit subsequent adhesion in RSV-infected cells. These data demonstrate that SAPS may have potential therapeutic value as a prophylactic treatment to modulate both RSV infection of AECs and the ensuing inflammatory response.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • McKenzie, Joanne
Advisors dc:contributor.advisor
  • Parker, Lisa
  • Sabroe, Ian
  • Bingle, Colin

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.861180
Dc Identifier Grantnumber
R/151413
R/164613

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

McKenzie, Joanne. Membrane microdomains as therapeutic targets to control respiratory syncytial virus. doctoral thesis, University of Sheffield, 2022.